Hisataka Kobayashi, M.D., Ph.D.
Hisataka  Kobayashi, M.D., Ph.D.
Senior Investigator
Head, Laboratory of Molecular Theranostics

Dr. Hisataka Kobayashi is the chief scientist in the Molecular Imaging Program at the National Cancer Institute/ NIH in Bethesda, MD. Dr. Kobayashi was awarded MD in 1987 and PhD (Immunology/Medicine) in 1995 from the Kyoto University, Kyoto, Japan. His interest is in developing the novel molecular imaging and therapeutic agents or technologies especially for targeting cancers. He has published over 250 scientific articles in clinical and preclinical bio-medical imaging over the last 20 years.

Areas of Expertise
molecular imaging

Contact Info

Hisataka Kobayashi, M.D., Ph.D.
Center for Cancer Research
National Cancer Institute
Bldg 10, Room B3B47
Bethesda, MD 20892-1088
301-435-4086
kobayash@mail.nih.gov
Selected Publications
  1. Harada T, Sano K, Sato K, Watanabe R, Yu Z, Hanaoka H, Nakajima T, Choyke PL, Ptaszek M, Kobayashi H.
    Bioconjug. Chem.. 25: 362-9, 2014. [ Journal Article ]
  2. Longmire MR, Ogawa M, Choyke PL, Kobayashi H.
    Wiley Interdiscip Rev Nanomed Nanobiotechnol. 6: 155-62, 2014. [ Journal Article ]
  3. Nakajima T, Sano K, Sato K, Watanabe R, Harada T, Hanaoka H, Choyke PL, Kobayashi H.
    Cancer Sci.. 105: 308-14, 2014. [ Journal Article ]
  4. Pang Y, Turkbey B, Bernardo M, Kruecker J, Kadoury S, Merino MJ, Wood BJ, Pinto PA, Choyke PL.
    Magn Res Med. 69: 553-62, 2013. [ Journal Article ]
  5. Mena E, Turkbey B, Mani H, Adler S, Valera VA, Bernardo M, Shah V, Pohida T, McKinney Y, Kwarteng G, Daar D, Lindenberg ML, Eclarinal P, Wade R, Linehan WM, Merino MJ, Pinto PA, Choyke PL, Kurdziel KA.
    J. Nucl. Med.. 53: 538-45, 2012. [ Journal Article ]

Dr. Hisataka Kobayashi is the chief scientist in the Molecular Imaging Program at the National Cancer Institute/ NIH in Bethesda, MD. Dr. Kobayashi was awarded MD in 1987 and PhD (Immunology/Medicine) in 1995 from the Kyoto University, Kyoto, Japan. His interest is in developing the novel molecular imaging and therapeutic agents or technologies especially for targeting cancers. He has published over 250 scientific articles in clinical and preclinical bio-medical imaging over the last 20 years.

Name Position
Toshiko Harada Special Volunteer
Tadanobu Nagaya Postdoctoral Fellow (Visiting)
Yuko Nakamura Ph.D. Visiting Fellow
Kazuhide Sato Postdoctoral Fellow (Visiting)

Publications

Selected Publications
  1. Harada T, Sano K, Sato K, Watanabe R, Yu Z, Hanaoka H, Nakajima T, Choyke PL, Ptaszek M, Kobayashi H.
    Bioconjug. Chem.. 25: 362-9, 2014. [ Journal Article ]
  2. Longmire MR, Ogawa M, Choyke PL, Kobayashi H.
    Wiley Interdiscip Rev Nanomed Nanobiotechnol. 6: 155-62, 2014. [ Journal Article ]
  3. Nakajima T, Sano K, Sato K, Watanabe R, Harada T, Hanaoka H, Choyke PL, Kobayashi H.
    Cancer Sci.. 105: 308-14, 2014. [ Journal Article ]
  4. Pang Y, Turkbey B, Bernardo M, Kruecker J, Kadoury S, Merino MJ, Wood BJ, Pinto PA, Choyke PL.
    Magn Res Med. 69: 553-62, 2013. [ Journal Article ]
  5. Mena E, Turkbey B, Mani H, Adler S, Valera VA, Bernardo M, Shah V, Pohida T, McKinney Y, Kwarteng G, Daar D, Lindenberg ML, Eclarinal P, Wade R, Linehan WM, Merino MJ, Pinto PA, Choyke PL, Kurdziel KA.
    J. Nucl. Med.. 53: 538-45, 2012. [ Journal Article ]

Biography

Dr. Hisataka Kobayashi is the chief scientist in the Molecular Imaging Program at the National Cancer Institute/ NIH in Bethesda, MD. Dr. Kobayashi was awarded MD in 1987 and PhD (Immunology/Medicine) in 1995 from the Kyoto University, Kyoto, Japan. His interest is in developing the novel molecular imaging and therapeutic agents or technologies especially for targeting cancers. He has published over 250 scientific articles in clinical and preclinical bio-medical imaging over the last 20 years.

Team

Name Position
Toshiko Harada Special Volunteer
Tadanobu Nagaya Postdoctoral Fellow (Visiting)
Yuko Nakamura Ph.D. Visiting Fellow
Kazuhide Sato Postdoctoral Fellow (Visiting)